Search

FDA Bans JUUL Products From US Market Cannabis industry stakeholders weigh in on what the decision could mean for businesses in the cannabis space. By Melissa Schiller On the other hand, Jonathan Havens, co-chair of Saul Ewing’s Cannabis Law Practice and chair of the firm’s Food, Beverage and...

FDA takes another look at CBD, but insiders are skeptical much will change U.S. health regulators are taking their closest look in more than three years at the idea of incorporating cannabinoids into dietary supplements. But hopes are dim that Tuesday’s daylong review by the U.S. Food and Drug...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice and Food, Beverage and Agribusiness Practice, will speak at the Food and Drug Law Institute’s Annual Conference as a panelist during the session on “Preparing for Federal Legalization of Cannabis: Lessons Learned from Other Industries.”...

Zachary Kobrin spoke on a panel titled, “A comparison of State Models” at the 6th Annual Canna Business & Wellness Conference and Expo, presented by the Cannabis Law, Accounting & Business (Cannabis LAB). The conference focused on the critical issues and challenges impacting the entire industry.

Saul Ewing LLP, a full-service law firm with attorneys in 16 offices, today announced that 59 attorneys from the Firm received the distinguished honor of being recognized for legal excellence and client service by Chambers USA 2022. Several of the Firm’s practice areas also earned high rankings...

Cannabis Law Partner Zachary Kobrin was featured in a CTFN article discussing the New York State Attorney General’s investigation into the Columbia Care/Cresco Labs merger. While the move by state authorities represents one of the first antitrust investigations of its kind into the cannabis industry...

FDA Warns Four Companies for Selling Unapproved Animal Drugs That Contain CBD The agency said in its warning letters that the drugs, which are intended for use in food-producing animals, violate the Federal Food, Drug, and Cosmetic Act. By Melissa Schiller Jonathan Havens, co-chair of the Cannabis...

Jonathan Havens, co-chair of the Firm's Cannabis Law Practice, and co-chair of the Firm's Food, Beverage and Agribusiness Practice, spoke at the Food and Drug Law Institute's 2022 Legal and Practical Issues in Cannabis Regulation Conference on May 25, 2022. Jonathan's topic was "Facilitating...

FACILITATING STAKEHOLDER COLLABORATION TO IMPROVE FUTURE CANNABIS REGULATION Jonathan Havens, Co-Chair of the Firm's Cannabis Law Practice, and Co-Chair of the Firm's Food, Beverage and Agribusiness Practice, will be speaking at the Food and Drug Law Institute's 2022 Legal and Practical Issues in...

AstraZeneca’s ambitious vaccine dreams are finally, officially dead One major caveat: even if the bill passes, it would be up to the FDA to decide when to crack down — and not everyone is convinced they will. “I’m, for one, a bit skeptical that this would immediately change [things] too much, unless...

Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...

In just two months, from mid-November 2020 to mid-January 2021, Saul Ewing LLP's Cannabis Law Practice assisted clients in closing transactions with a combined deal value of more than $520 million. We served as: U.S. counsel to Canaccord Genuity Corp. , lead underwriter of an overnight marketed...